IPEC-Americas recently published a position paper outlining issues and concerns within the existing IID.
This paper describes the position of IPEC-Americas on implementation of the NSF/IPEC/ANSI 363-2014 Good Manufacturing Practices (GMP) for Pharmaceutical Excipients.
Members of the IPEC-Americas Safety Committee working group on Phthalates dispel some misunderstandings about excipients that contain the word "phthalate" in their name. Article may be downloaded.
The Coalition for Rational Implementation of the USP Elemental Impurities Requirements provided comments to USP which are related to the sample preparation methods in USP General Chapter <233>.
Several countries are requiring excipient suppliers to supply Certificates before they will allow the excipients to be imported into the country.